Population Level Screening to Detect Early Stage Type 1 Diabetes

Show notes

Watch the full video from the EASD 2025 Annual Meeting to learn more about the emerging global consensus on screening for early-stage type 1 diabetes and its implications for clinical practice, public health, and prevention research.

In this episode, Annette Ziegler (Helmholtz Munich), Chantal Mathieu (KU Leuven & EASD President), and Anastasia Albanese-O’Neill (Breakthrough T1D) discuss:

  • Why early detection matters for preventing diabetic ketoacidosis
  • Recommended screening ages and the three-time childhood screening model
  • The two-step testing approach and its >99% specificity
  • How early diagnosis enables access to disease-modifying therapies
  • Policy considerations for national and regional screening programmes
  • Future directions, including genetic and polygenic risk screening

Stay tuned for more expert insights and breakthrough conversations from EASD TV. To learn more about our expert speakers:

New comment

Your name or nickname, will be shown publicly
At least 10 characters long
By submitting your comment you agree that the content of the field "Name or nickname" will be stored and shown publicly next to your comment. Using your real name is optional.